354200 — NGeneBio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for NGeneBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-8,431	-9,839	-12,860	—	-6,757
Depreciation
Amortisation
Non-Cash Items	841	2,290	1,666	-1,222	-1,345
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-963	-1,545	683	-14,145	-2,615
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-7,523	-7,820	-9,167	-12,431	-8,490
Capital Expenditures	-3,372	-1,225	-828	-239	-136
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-14,006	1,810	4,959	-5,758	-26,790
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-17,378	585	4,131	-5,997	-26,927
Financing Cash Flow Items	—	130	—	2,022	981
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,895	15,797	-608	3,553	32,980
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-23,006	8,601	-5,623	-14,844	-2,488